OutSense

About:

OutSensedevelops an IOT sensor for early detection of illness and as wellness monitoring tool.

Website: https://outsensediagnostics.com

Top Investors: EASME - EU Executive Agency for SMEs, Peregrine Ventures, Longevity Venture Partners

Description:

OutSensedevelops an IOT sensor for early detection of illness and as wellness monitoring tool. A medical status report for each person is generated daily in the form of our biological excretions. OutSense is using innovative imaging technologies to reveal this information. The sensor will monitor essential health and wellness parameters and communicate them with a mobile device app. The primary goal is to prevent colorectal cancer by identifying hidden blood in stool. Hidden blood is a well-established screening tool for colorectal cancer (CRC), currently performed by sending a stool sample to a specialized lab.

Total Funding Amount:

$2.87M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nahsholim, Hefa, Israel

Founded Date:

2015-01-01

Founders:

Ishay Attar, Tali Triebitz, Yaara Kapp-Barnea, Yfat Scialom

Number of Employees:

1-10

Last Funding Date:

2021-06-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai